Kamunting Street Capital Management, L.P. Vbi Vaccines Inc Call Options Transaction History

Kamunting Street Capital Management, L.P.

  • $91.6 Million
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding VBIV

# of Institutions
2
Shares Held
688K
Call Options Held
0
Put Options Held
0
View Full List

About VBI Vaccines Inc

VBIV Quotes by TradingView
  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Kamunting Street Capital Management, L.P. Portfolio

Follow Kamunting Street Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kamunting Street Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Kamunting Street Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email